Cookie Dash v. Roche Laboratories Roche Dermatologics Roche Products, Inc. Richard Salit, and Hoffman-La Roche, Inc.

Good Law
74 F.3d 1245·1996 WL 12588·1996 U.S. App. LEXIS 38913
United States Court of Appeals for the Ninth CircuitJanuary 11, 199694-55814California1,269 words

Opinion

Opinion

74 F.3d 1245 NOTICE: Ninth Circuit Rule 36-3 provides that dispositions other than opinions or orders designated for publication are not precedential and should not be cited except when relevant under the doctrines of law of the case, res judicata, or collateral estoppel. Cookie DASH, Plaintiff-Appellant, v. ROCHE LABORATORIES; Roche Dermatologics; Roche Products, Inc.; Richard Salit, Defendants. and Hoffman-La Roche, Inc., Defendant-Appellee. No. 94-55814. United States Court of Appeals, Ninth Circuit. Argued and Submitted Dec. 15, 1995. Decided Jan. 11, 1996. 1 Before: ALARCON and RYMER, Circuit Judges, and QUACKENBUSH, * Senior District Judge. 2 MEMORANDUM ** 3 Plaintiff-appellant Cookie Dash appeals from the district court's order granting summary judgment in favor of defendant-appellee Hoffman-La Roche, Inc. ("Roche") in this products liability action. Dash contends that the district court erred in granting summary judgment because there is a genuine issue of material fact whether Roche's warnings were adequate. We affirm because Roche expressly warned physicians prescribing Accutane that a possible side effect of its use is that it may cause persistent or permanent eye…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.